Misplaced Pages

Trimethoprim/polymyxin B

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by BogBot (talk | contribs) at 01:45, 21 September 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 01:45, 21 September 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Trimethoprim/polymyxin B" – news · newspapers · books · scholar · JSTOR (February 2011) (Learn how and when to remove this message)
Pharmaceutical compound
Trimethoprim/polymyxin B
Combination of
TrimethoprimNucleic acid inhibitor antibiotic
PolymyxinCell envelope antibiotic
Clinical data
Routes of
administration
Eye drops
ATC code
Identifiers
PubChem CID
CompTox Dashboard (EPA)
  (verify)

The drug combination trimethoprim/polymyxin (INNs, trade name Polytrim) is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: